(Q54511799)

30 May 2018

title

Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis. (English)

1 reference

30 May 2018

0 references

2

1 reference

30 May 2018

Pere-Joan Cardona i Iglesias

6

1 reference

30 May 2018

Elena Marzo

1

object named as

Elena Marzo

1 reference

30 May 2018

author name string

Gustavo Tapia

3

1 reference

30 May 2018

Jorge Diaz

4

1 reference

30 May 2018

Vanessa Garcia

5

1 reference

30 May 2018

publication date

19 September 2013

1 reference

30 May 2018

published in

Tuberculosis

1 reference

30 May 2018

volume

94

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

55-64

1 reference

30 May 2018

A dynamic reinfection hypothesis of latent tuberculosis infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

The damage-response framework of microbial pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated Adversary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Genetic architecture of tuberculosis resistance in a mouse model of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Ipr1 gene mediates innate immunity to tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Multigenic control of tuberculosis resistance: analysis of a QTL on mouse chromosome 7 and its synergism with sst1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Cavitation in pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

A spotlight on liquefaction: evidence from clinical settings and experimental models in tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

MMP-1 drives immunopathology in human tuberculosis and transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

A play in four acts: Staphylococcus aureus abscess formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Neutrophils in tuberculosis: friend or foe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Inhibition of neutrophil activation by nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Beneficial suicide: why neutrophils die to make NETs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Novel cell death program leads to neutrophil extracellular traps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Neutrophil extracellular traps are induced by Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Aspirin preserves neutrophil apoptosis after cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Regulation of apoptosis in eicosapentaenoic acid-treated HL-60 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Aspirin and salicylate suppress polymorphonuclear apoptosis delay mediated by proinflammatory stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

Nonsteroidal Antiinflammatory Drugs for Adjunctive Tuberculosis Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.09.004

10.1016/J.TUBE.2013.09.004

7 January 2021

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018